AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
1-Year Return 29.75%
This Quarter Return
-5.47%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
10 Year Return
AUM
$183M
AUM Growth
-$69.6M
Cap. Flow
-$68M
Cap. Flow %
-37.21%
Top 10 Hldgs %
66.27%
Holding
69
New
6
Increased
13
Reduced
11
Closed
14
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OBIO icon
51
Orchestra BioMed
OBIO
$148M
-300,000
Closed -$2.97M
PMVP icon
52
PMV Pharmaceuticals
PMVP
$76.3M
0
PTGX icon
53
Protagonist Therapeutics
PTGX
$3.71B
-300,000
Closed -$7.1M
RENB icon
54
Renovaro
RENB
$49.3M
0
RLAY icon
55
Relay Therapeutics
RLAY
$690M
0
SPY icon
56
SPDR S&P 500 ETF Trust
SPY
$662B
0
SWTX
57
DELISTED
SpringWorks Therapeutics
SWTX
-247,000
Closed -$13.9M
TVTX icon
58
Travere Therapeutics
TVTX
$1.89B
-100,000
Closed -$2.58M
XENE icon
59
Xenon Pharmaceuticals
XENE
$2.98B
-80,000
Closed -$2.45M
CERE
60
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-70,000
Closed -$2.45M
NSTG
61
DELISTED
NanoString Technologies, Inc.
NSTG
-171,592
Closed -$5.96M
MSAC
62
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
-300,000
Closed -$2.93M
GBT
63
DELISTED
Global Blood Therapeutics, Inc.
GBT
-70,000
Closed -$2.43M
ATHX
64
DELISTED
Athersys, Inc. Common Stock
ATHX
0
CALA
65
DELISTED
Calithera Biosciences, Inc
CALA
-50,000
Closed -$404K